Published in Blood Weekly, October 31st, 2002
The researchers reviewed data from 21 patients who developed acute or chronic GvHD after stem cell...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.